Genomic Messaging System and DNA Mark-Up Language for Information-Based Personalized Medicine with Clinical and Proteome Research Applications

Barry Robson and Richard Mushlin
IBM Research, T.J. Watson Research Lab., Route 132, Yorktown Heights, New York 10598
Journal of Proteome Research, 2004, 3 (5), pp 930–948
DOI: 10.1021/pr0341336
Publication Date (Web): July 22, 2004
Copyright © 2004 American Chemical Society

Abstract

Abstract Image

The convergence of clinical medicine and the Life Sciences, commencing with opportunities in clinical trials and clinically linked medical research, presents many novel challenges. The Genomic Messaging System (GMS) described here was originally developed as a tool for assembling clinical genomic records of individual and collective patients, and was then generalized to become a flexible workflow component that will link clinical records to a variety of computational biology research tools, for research and ultimately for a more personalized, focused, and preventative healthcare system. Prominent among the applications linked are protein science applications, including the rapid automated modeling of patient proteins with their individual structural polymorphisms. In an initial study, GMS formed the basis of a fully automated system for modeling patient proteins with structural polymorphisms as a basis for drug selection and ultimately design on an individual patient basis.

Keywords: bioinformatics • genomics • sequence compression • DNA mark-up • genomics language • personalized medicine • clinical messaging

Tools

SciFinder Links

SciFinder subscribers:  Click to sign in | Not a SciFinder subscriber? Learn more at www.cas.org

History

  • Published In Issue October 11, 2004
  • Received December 31, 2003

Recommend & Share

Related Content

Other ACS content by these authors: